Hit-to-lead drug development

Hit-to-lead drug development administraT0R 2020-06-25T11:27:59+00:00

Discovery methods

Recepton’s integrated panel of drug discovery methods includes:

NMR fragment-based drug discovery
High throughput screening by HTRF
ELISA
AIDA-NMR
Cell-based assays
ADME